Abstract
Aging is a natural process defined as a progressive decline in physiological functions which lead to increased risk of diseases and death. Recent advances in antiaging intervention have focused on stem cell-based therapies and cell reprogramming. The development of stem cell reprogramming to fight the aging process has recently become important issue in antiaging strategies. Stem cell-based therapies and cell reprogramming have provided various strategies to alter somatic cell identity into induced-pluripotent stem cell. Stem cells are defined as pluripotent cells that possess both the abilities of self-renewal and differentiation toward numerous cell types. Cell reprogramming is simply composed of deleting cell memory and rewriting new identity of somatic cell. Stem cell reprogramming has provided enormous insight on regenerative medicine for antiaging. This chapter has focused on potential role of stem cell reprogramming to slow down aging process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akunuru S, Geiger H (2016) Aging, clonality, and rejuvenation of hematopoietic stem cells. Trends Mol Med 22(8):701–712
Aoi T, Yae K, Nakagawa M et al (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699–702
Avasthi S, Srivastava RN, Singh A et al (2008) Stem cells: past, present, future –a review article. Internet J Med Update 3(1):22–30
Barrilleaux B, Phinney DG, Prockop DJ et al (2006) Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12:3007–3019
Behfar A, Perez-Terzic C, Faustino RS et al (2007) Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 204:405–420
Bernet JD, Doles JD, Hall JK et al (2014) p38 MAPK signaling underlies a cellautonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat Med 20:265–271
Bindu HA, Srilatha B (2011) Potency of various types of stem cells and their transplantation. J Stem Cell Res Ther 1(3):115
Blanpain C, Horsley V, Fuchs E (2007) Epithelial stem cells: turning over newleaves. Cell 128:445–458
Blau HM, Brazelton TR, Weimman JM (2001) The evolving concept of a stem cell: entity or function? Cell 106:829–841
Boyette LB, Tuan RS (2014) Adult stem cells and diseases of aging. J Clin Med 3(1):88–134
Carmona JJ, Michan S (2016) Biology of healthy aging and longevity. Rev Investig Clin 68:7–16
Collins CA, Zammit PS, Ruiz AP et al (2007) A population of myogenic stem cells that survives skeletal muscle aging. Stem Cells 25:885–894
Cosgrove BD, Gilbert PM, Porpiglia E et al (2014) Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med 20:255–264
Donmez G, Guarente L (2010) Aging and disease: connections to sirtuins. Aging Cell 9(2):285–290
Dykstra B, Olthof S, Schreuder J et al (2011) Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells. J Exp Med 208:2691–2703
Feng R, Desbordes SC, Xie H et al (2008) PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci U S A 105(16):6057–6062
Gardner RL (2002) Stem cells: potency, plasticity and public perception. J Anat 200:277–282
Griscelli F, Oudrhiri N, Feraud O et al (2017) Generation of induced pluripotent stem cell (iPSC) line from a patient with triple negative breast cancer with hereditary exon 17 deletion of BRCA1 gene. Stem Cell Res 24:135–138
Hall JA, Dominy JE, Lee Y et al (2013) The sirtuin family’s role in aging and age-associated pathologies. J Clin Invest 123(3):973–979
Hallett PJ, Deleidi M, Astradsson A et al (2015) Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson’s disease. Cell Stem Cell 16(3):269–274
Heman-Ackah SM, Manzano R, Hoozemans JJ et al (2017) Alpha-synuclein induces the unfolded protein response in Parkinson’s disease SNCA triplication iPSC-derived neurons. Hum Mol Genet 26(22):4441–4450
Hirami Y, Osakada F, Takahashi K et al (2009) Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 458(3):126–131
Ichida J, Blanchard J, al Lam K (2009) A small-molecule inhibitor of Tgfbeta signaling replaces Sox2 in reprogramming by inducing Nanog. Cell Stem Cell 5:491–503
Ieda M, Fu JD, Delgado-Olguin P et al (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142(3):375–386
Jeevani T (2011) Stem cell transplantation-types, risks and benefits. J Stem Cell Res Ther 1(3):114
Jones VC, Atkinson-Dell R, Verkhratsky A et al (2017) Aberrant iPSC-derived human astrocytes in Alzheimer’s disease. Cell Death Dis 8(3):2696
Kalra K, Tomar P (2014) Stem cell: basics, classification and applications. Am J Phyto Med Clin Ther:919–930
Kasper G, Mao L, Geissler S et al (2009) Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells 27(6):1288–1297
Kudva YC, Ohmine S, Greder LV et al (2012) Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med 1(6):451–461
Lapasset L, Milhavet O, Prieur A et al (2011) Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev 25:2248–2253
Lavu S, Boss O, Elliott PJ et al (2008) Sirtuins – novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 7(10):841
Lepperdinger G, Brunauer R, Gassner R et al (2008) Changes of the functional capacity of mesenchymal stem cells due to aging or age-associated disease–implications for clinical applications and donor recruitment. Transfus Med Hemother 35(4):299–305
Liu GH, Barkho BZ, Ruiz S et al (2011) Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472:221–225
López-León M, Outeiro TF, Goya RG (2017) Cell reprogramming: therapeutic potential and the promise of rejuvenation for the aging brain. Ageing Res Rev 40:168–181
Majo F, Rochat A, Nicolas M et al (2008) Oligopotentstem cells are distributed throughout the mammalian ocular surface. Nature 456:250–254
McGuckin CP, Jurga M, Miller AM et al (2013) Ischemic brain injury: a consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction. Arch Biochem Biophys 534(1–2):88–97
Mimeault M, Hauke R, Batra SK (2007) Stem cells: a revolution in therapeutics—recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82(3):252–264
Moore KA, Lemischka IR (2006) Stem cells and their niches. Science 311(5769):1880–1885
Narazaki G, Uosaki H, Teranishi M et al (2008) Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118(5):498–506
Niu W, Zang T, Smith DK et al (2015) SOX2 reprograms resident astrocytes into neural progenitors in the adult brain. Stem Cell Rep 4(5):780–794
Noda S, Ichikawa H, Miyoshi H (2009) Hematopoietic stem cell aging is associated with functional decline and delayed cell cycle progression. Biochem Biophys Res Commun 383(2):210–215
Ocampo A, Reddy P, Martinez-Redondo P et al (2016) In Vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167(7):1719–1733
Oh J, Lee YD, Wagers AJ (2014) Stem cell aging: mechanisms,regulators and therapeutic opportunities. Nat Med 20:870–880
Ohmine S, Squillace KA, Hartjes KA et al (2012) Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY) 4(1):60–73
Pfisterer U, Kirkeby A, Torper O et al (2011) Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A 108(25):10343–10348
Qi X, Zhang J, Yuan H et al (2016) Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int J Biol Sci 12(7):836
Qian L, Huang Y, Spencer CI et al (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485(7400):593
Qiu X, Sun C, Yu W et al (2012) Combined strategy of mesenchymal stem cell injection with vascular endothelial growth factor gene therapy for the treatment of diabetes-associated erectile dysfunction. J Androl 33:37–44
Rando TA, Chang HY (2012) Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148(1):46–57
Rezvani M, Español-Suñer R, Malato Y et al (2016) In vivo hepatic reprogramming of myofibroblasts with AAV vectors as a therapeutic strategy for liver fibrosis. Cell Stem Cell 18(6):809–816
Senju S, Haruta M, Matsunaga Y et al (2009) Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cell 27(5):1021–1031
Sharma A, Diecke S, Zhang WY et al (2013) The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J Bio Chem 288(25):18439–18447
Smith A (2001) Embryonic stem cells. Cold Spring Harb Monogr Ser 40:205–230
Snykers S, Kock JD, Rogiers V et al (2009) In vitro differentiation of embryonic and adult stem cells into hepotocytes: state of the art. Stem Cells 27:577–605
Somers A, Jean JC, Sommer CA et al (2010) Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28:1728–1740
Song G, Pacher M, Balakrishnan A et al (2016) Direct reprogramming of hepatic myofibroblasts into hepatocytes in vivo attenuates liver fibrosis. Cell Stem Cell 18(6):797–808
Taguchi J, Yamada Y (2017) In vivo reprogramming for tissue regeneration and organismal rejuvenation. Curr Opin Genet Dev 46:132–140
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Torper O, Pfisterer U, Wolf DA et al (2013) Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci U S A 110(17):7038–7043
Toustrup LB, Zhou Y, Kvistgaard H et al (2017) Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP gene. Stem Cell Res 19:37–42
Uhlenhaut NH, Jakob S, Anlag K et al (2009) Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139(6):1130–1142
Vakhrusheva O, Smolka C, Gajawada P et al (2008) Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 102:703–710
Valarmathi MT, Fuseler JW (2011) Mammalian cardiac muscle regeneration:structural and functional modulation of adult marrow stromal stem cells. Anatom Physiol 1:102
Verfaillie CM, Pera MF, Lansdorp PM (2002) Stem cells: hype and reality. Am Soc Hem Educ Program 2002(1):369–391
Vierbuchen T, Ostermeier A, Pang ZP et al (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463(7284):1035
Vilchez D, Simic MS, Dillin A (2013) Proteostasis and aging of stem cells. Trends Cell Biol 24:161–170
Xie H, Ye M, Feng R et al (2004) Stepwise reprogramming of B cells into macrophages. Cell 117(5):663–676
Yagi T, Kosakai A, Ito D et al (2012) Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One 7(7):41572
Yagi H, Tan J, Tuan RS (2013) Polyphenols suppress hydrogen peroxide-induced oxidative stress in human bone-marrow derived mesenchymal stem cells. J Cell Biochem 114(5):1163–1173
Yang J, Li S, He XB, Cheng C, Le W (2016) Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy. Mol Neurodegener 11(1):39
Young HE, Black AC Jr (2004) Adult stem cells. Anat Rec A Discov Mol Cell Evol Biol 276:75–102
Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920
Zhang J, Lian Q, Zhu G et al (2011) A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8:31–45
Zhou Q, Brown J, Kanarek A et al (2008) In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455(7213):627
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Orta Yilmaz, B., Erkan, M. (2018). The Potential Role of Stem Cell Reprogramming in Antiaging. In: Rizvi, S., Çakatay, U. (eds) Molecular Basis and Emerging Strategies for Anti-aging Interventions. Springer, Singapore. https://doi.org/10.1007/978-981-13-1699-9_3
Download citation
DOI: https://doi.org/10.1007/978-981-13-1699-9_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1698-2
Online ISBN: 978-981-13-1699-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)